Blood pressure-oriented versus blood flow-oriented circulatory management for preventing intraventricular hemorrhage in VLBW infants during first 7 days: a randomized trial
Phase 2
- Conditions
- cardiovascular failure in very low birth weight infants
- Registration Number
- JPRN-UMIN000013296
- Lead Sponsor
- Saitama Medical Center, Saitama Medical University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 440
Inclusion Criteria
Not provided
Exclusion Criteria
chromosomal anomaly major anomaly congenital heart disease severe asphyxia Gestationalage less than 22 weeks
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie intraventricular hemorrhage in VLBW infants with cardiovascular failure?
How does blood pressure-oriented management compare to blood flow-oriented approaches in preventing IVH in VLBW infants?
Are there specific biomarkers that predict risk of IVH in VLBW infants undergoing circulatory management?
What are the potential adverse effects of circulatory management strategies in VLBW infants and how are they managed?
What combination therapies or alternative approaches are being explored for cardiovascular failure in VLBW infants?